Fenofibrate treatment enhances antioxidant status and attenuates endothelial dysfunction in streptozotocin-induced diabetic rats

Experimental Diabetes Research

Volumn 2010, Issue , 2010, Pages

  Olukman, Murat ^a   Sezer, Ebru Demirel ^a   Ülker, Sibel ^a   Szmen, Eser Y ^a   Çnar, Gülcihan Mehtap ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CHOLESTEROL; ENDOTHELIUM DERIVED RELAXING FACTOR; FENOFIBRATE; HOMOCYSTEINE; MYELOPEROXIDASE; NITRIC OXIDE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; LIPID; PEROXIDASE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENZYME BLOOD LEVEL; ERYTHROCYTE; INFLAMMATION; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; AORTA, THORACIC; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FENOFIBRATE; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PEROXIDASE; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952268700     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2010/828531     Document Type: Article

References (49)

1. Zimmet P., Alberti K. G. M. M., Shaw J., Global and societal implications of the (Pubitemid 34000780)
2. Schalkwijk C. G., Stehouwer C. D. A., Vascular complications in diabetes mellitus: the role of endothelial dysfunction Clinical Science 2005 109 2 143 159 (Pubitemid 41117297)
3. Kanie N., Matsumoto T., Kobayashi T., Kamata K., Relationship between peroxisome proliferator-activated receptors (PPAR and PPAR ) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats British Journal of Pharmacology 2003 140 1 23 32 (Pubitemid 37175827)
4. Furchgott R. F., Zawadzki J. V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 1980 288 5789 373 376 (Pubitemid 11169009)
5. Johnstone M. T., Creager S. J., Scales K. M., Cusco J. A., Lee B. K., Creager M. A., Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus Circulation 1993 88 6 2510 2516 (Pubitemid 23360174)
6. McVeigh G. E., Brennan G. M., Johnston G. D., McDermott B. J., McGrath L. T., Henry W. R., Andrews J. W., Hayes J. R., Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 1992 35 8 771 776
7. Bayraktutan U., Free radicals, diabetes and endothelial dysfunction Diabetes, Obesity and Metabolism 2002 4 4 224 238 (Pubitemid 34814863)
8. Makino N., Maeda T., Sugano M., Satoh S., Watanabe R., Abe N., High serum TNF- level in type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells Journal of Diabetes and its Complications 2005 19 6 347 355 (Pubitemid 41563018)
9. Podrez E. A., Abu-Soud H. M., Hazen S. L., Myeloperoxidase-generated oxidants and atherosclerosis Free Radical Biology and Medicine 2000 28 12 1717 1725 (Pubitemid 30628658)
10. Heinecke J. W., Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis American Journal of Cardiology 2003 91 3, supplement S 12A 16A (Pubitemid 36351458)
11. Araki A., Homocysteine and diabetic macroangiopathy Japanese Journal of Clinical Medicine 2006 64 11 2153 2158
12. Mayer O., imon J., Holubec L., Pikner R., Trefil L., Folate co-administration improves the effectiveness of fenofibrate to decrease the lipoprotein oxidation and endothelial dysfunction surrogates Physiological Research 2006 55 5 475 481 (Pubitemid 44611192)
13. Desouza C. V., Murthy S. N., Diez J., Dunne B., Marta A. S., Fonseca V. A., McNamara D. B., Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after ballon catheter-induced vascular injury in Zucker rats Journal of Cardiovascular Pharmacology and Therapeutics 2003 8 4 297 305 (Pubitemid 38045081)
14. Koh E. H., Kim M. S., Park J. Y., Kim H. S., Youn J. Y., Park H. S., Youn J. H., Lee K. U., Peroxisome proliferator-activated receptor (PPAR)- activation prevents diabetes in OLETF rats: comparison with PPAR- activation Diabetes 2003 52 9 2331 2337 (Pubitemid 37059504)
15. Yang T. L., Chen M. F., Luo B. L., Yu J., Jiang J. L., Li Y. J., Effect of fenofibrate on LDL-induced endothelial dysfunction in rats Naunyn-Schmiedeberg's Archives of Pharmacology 2004 370 2 79 83 (Pubitemid 39222858)
16. Li S., Gokden N., Okusa M. D., Bhatt R., Portilla D., Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF American Journal of Physiology 2005 289 2 F469 F480
17. Melenovsky V., Stulc T., Kozich V., Grauova B., Krijt J., Wichterle D., Haas T., Malik J., Hradec J., Ceska R., Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine American Heart Journal 2003 146 1 1 6
18. Legendre C., Causs E., Chaput E., Salvayre R., Pineau T., Edgar A. D., Fenofibrate induces a selective increase of protein-bound homocysteine in rodents: a PPAR -mediated effect Biochemical and Biophysical Research Communications 2002 295 5 1052 1056
19. Szmen E. Y., Tanyalin T., Onat T., Kutay F., Erlain S., Ethanol induced oxidative stress and membrane injury in rat erythrocytes European Journal of Clinical Chemistry and Clinical Biochemistry 1994 32 10 741 744 (Pubitemid 24325333)
20. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., Protein measurement with the Folin phenol reagent The Journal of Biological Chemistry 1951 193 1 265 275
21. Grisham M. B., Anzueto Hernandez L., Granger D. N., Xanthine oxidase and neutrophil infiltration in intestinal ischemia American Journal of Physiology 1986 251 4 567 574
22. Balakumar P., Chakkarwar V. A., Singh M., Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat Molecular and Cellular Biochemistry 2009 320 1-2 149 162
23. Wang P. R., Guo Q., Ippolito M., Wu M., Milot D., Ventre J., Doebber T., Wright S. D., Chao YU. S., High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists European Journal of Pharmacology 2001 427 3 285 293 (Pubitemid 32913296)
24. Betowski J., Wjcicka G., Mydlarczyk M., Jamroz A., The effect of peroxisome proliferator-activated receptors (PPAR ) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON1) activity Journal of Physiology and Pharmacology 2002 53 3 463 475
25. Kanie N., Matsumoto T., Kobayashi T., Kamata K., Relationship between peroxisome proliferator-activated receptors (PPAR and PPAR ) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats British Journal of Pharmacology 2003 140 1 23 32 (Pubitemid 37175827)
26. Anwer T., Sharma M., Pillai K. K., Haque S. E., Alam M. M., Zaman M. S., Protective effect of bezafibrate on streptozotocin-induced oxidative stress and toxicity in rats Toxicology 2007 229 1-2 165 172 (Pubitemid 44881171)
27. Dierkes J., Westphal S., Martens-Lobenhoffer J., Luley C., Bode-Bger S. M., Fenofibrate increases the L-arginine: ADMA ratio by increase of L-arginine concentration but has no effect on ADMA concentration Atherosclerosis 2004 173 2 239 244 (Pubitemid 38469791)
28. Moldoveanu E., Tanaseanu C., Tanaseanu S., Kosaka T., Manea G., Marta D. S., Popescu L. M., Plasma markers of endothelial dysfunction in type 2 diabetics European Journal of Internal Medicine 2006 17 1 38 42 (Pubitemid 43003460)
29. Kobayashi T., Kamata K., Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats Atherosclerosis 2001 155 2 313 320 (Pubitemid 32209301)
30. Pieper G. M., Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration Diabetologia 1999 42 2 204 213 (Pubitemid 29064243)
31. zelikay A. T., Tay A., Diner D., Meral S., Yildizoglu-Ari N., Altan V. M., The effects of chronic L-arginine treatment on vascular responsiveness of streptozotocin-diabetic rats General Pharmacology 1999 33 4 299 306 (Pubitemid 29465735)
32. Majithiya J. B., Paramar A. N., Balaraman R., Pioglitazone, a PPAR agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats Cardiovascular Research 2005 66 1 150 161 (Pubitemid 40357878)
33. Alper G., Olukman M., Irer S., alayan O., Duman E., Yilmaz C., lker S., Effect of vitamin E and C supplementation combined with oral antidiabetic therapy on the endothelial dysfunction in the neonatally streptozotocin injected diabetic rat Diabetes/Metabolism Research and Reviews 2006 22 3 190 197 (Pubitemid 43805399)
34. Ozansoy G., Akin B., Aktan F., Karasu C., Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats Molecular and Cellular Biochemistry 2001 216 1-2 59 63 (Pubitemid 32142224)
35. Richards R. S., Roberts T. K., Dunstan R. H., McGregor N. R., Butt H. L., Erythrocyte antioxidant systems protect cultured endothelial cells against oxidant damage Biochemistry and Molecular Biology International 1998 46 5 857 865 (Pubitemid 29004596)
36. Toth K. M., Clifford D. P., Berger E. M., Intact human erythrocytes prevent hydrogen peroxide-mediated damage to isolated perfused rat lungs and cultured bovine pulmonary artery endothelial cells Journal of Clinical Investigation 1984 74 1 292 295 (Pubitemid 14086072)
37. Heilman K., Zilmer M., Zilmer K., Lintrop M., Kampus P., Kals J., Tillmann V., Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes Diabetes Research and Clinical Practice 2009 84 2 168 173
38. Gao X., Belmadani S., Picchi A., Xu X., Potter B. J., Tewari-Singh N., Capobianco S., Chilian W. M., Zhang C., Tumor necrosis factor- induces endothelial dysfunction in Leprdb mice Circulation 2007 115 2 245 254 (Pubitemid 46105724)
39. Yang T. L., Chen M. F., Luo B. L., Yu J., Jiang J. L., Li Y. J., Effect of fenofibrate on LDL-induced endothelial dysfunction in rats Naunyn-Schmiedeberg's Archives of Pharmacology 2004 370 2 79 83 (Pubitemid 39222858)
40. Choi K. C., Ryu O. H., Lee K. W., Kim H. Y., Seo J. A., Kim S. G., Kim N. H., Choi D. S., Baik S. H., Choi K. M., Effect of PPAR- and- agonist on the expression of visfatin, adiponectin, and TNF- in visceral fat of OLETF rats Biochemical and Biophysical Research Communications 2005 336 3 747 753 (Pubitemid 41338332)
41. Wiltshire E. J., Mohsin F., Chan A., Donaghue K. C., Methylenetetrahydrofolate reductase and methionine synthase reductase gene polymorphisms and protection from microvascular complications in adolescents with type 1 diabetes Pediatric Diabetes 2008 9 4, part 2 349 358
42. Unlucerci Y., Bekpinar S., Grdl F., Seferoglu G., A study on the relationship between homocysteine and diabetic nephropathy in rats Pharmacological Research 2002 45 3 249 252 (Pubitemid 35428789)
43. Desouza C. V., Murthy S. N., Diez J., Dunne B., Marta A. S., Fonseca V. A., McNamara D. B., Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats Journal of Cardiovascular Pharmacology and Therapeutics 2003 8 4 297 305 (Pubitemid 38045081)
44. Ismail-Beigi F., Craven T., Banerji M. A., Basile J., Calles J., Cohen R. M., Cuddihy R., Cushman W. C., Genuth S., Grimm R. H. Jr., Hamilton B. P., Hoogwerf B., Karl D., Katz L., Krikorian A., O'Connor P., Pop-Busui R., Schubart U., Simmons D., Taylor H., Thomas A., Weiss D., Hramiak I., Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial The Lancet 2010 376 9739 419 430
45. Keech A., Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial Lancet 2005 366 9500 1849 1861
46. Hiukka A., Westerbacka J., Leinonen E. S., Watanabe H., Wiklund O., Hulten L. M., Salonen J. T., Tuomainen T. P., Yki-Jrvinen H., Keech A. C., Taskinen M. R., Long-term effects of fenofibrate on carotid intimamedia thickness and augmentation index in subjects with type 2 diabetes mellitus Journal of the American College of Cardiology 2008 52 25 2190 2197
47. Hogue J. C., Lamarche B., Tremblay A. J., Bergeron J., Gagn C., Couture P., Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus Metabolism 2008 57 3 380 386 (Pubitemid 351178728)
48. Desideri G., Croce G., Tucci M., Passacquale G., Broccoletti S., Valeri L., Santucci A., Ferri C., Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipidlowering treatments Journal of Clinical Endocrinology and Metabolism 2003 88 11 5341 5347 (Pubitemid 37452737)
49. Playford D. A., Watts G. F., Croft K. D., Burke V., Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes Atherosclerosis 2003 168 1 169 179 (Pubitemid 36555825)